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Inositol 1,3,4-trisphosphate (Ins(1,3,4)P3) metabolism has been studied in liver homogenates and in 100,000 X g supernatant and particulate fractions. When liver homogenates were incubated in an "intracellular" medium containing 5 m M MgATP, equal proportions of Ins(1,3,4)P3 were dephosphorylated and phosphorylated. Two inositol tetrakisphosphate (InsP4) products and an inositol pentakisphosphate (Imp5) were detected. The InsP4 isomers were unequivocally identified as inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4) and inositol 1,3,4,6-tetrakisphosphate (Ins(1,3,4,6)P4) by high performance liquid chromatography separation of inositol phosphates, periodate oxidation, alkaline hydrolysis, and stereospecific polyol dehydrogenase. Ins(1,3,4)P3 5-kinase is a novel enzyme activity and accounted for 16% of the total Ins(1,3,4)P3 phosphorylation. Ins(1,3,4,6)P4 was also shown to be further phosphorylated to inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)Ps) by a kinase not previously known to occur in liver. About 75% of Ins(1,3,4)P3 kinase activities were soluble and were partly purified by anion-exchange fast protein liquid chromatography. The two Ins(1,3,4)P3 kinase activities eluted as a single peak that was well resolved from Ins( 1,3,4)P3 phosphatase, Ins(1,3,4,6)P4 5-kinase, and Ins(1,3,4,5)P4 5-phosphatase activities. A further novel observation was that 1 0 pm Ins(1,3,4,5)P4 inhibited lns(1,3,4)P3 kinase activities by 60%.
It is well known that receptor-mediated activation of phospholipase C promotes hydrolysis of phosphatidylinositol 4,5-bisphosphate to yield two intracellular messengers, Ins(1,4,5)Pi and 1,2-diacylglycerol; the inositol phosphate mobilizes intracellular Ca2+ stores, and 1,2-diacylglycerol activates protein kinase C, and these effects are important in the regulation of cell function (see Ref. 1 for review). The metabolism of these intracellular messengers terminates the * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "aduertisernent" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Ins, InsP, Ins€ ', , InsPs, InsP4, InsP, , and InsP, and its mono-, bis-, tris-, tetrakis-, pentakis-, and hexakisphosphates with locants designated as appropriate according to the 1-D nomenclature (see Ref. 33) : the other abbreviations used are: BisTris, bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane; EGTA, [ethylenebis(oxyethylenenitrilo)]tetraacetic acid; FPLC,. fast protein liquid chromatography; Hepes, 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid HPLC, high performance liquid chromatography. signaling response. Additionally, the complexities of the pathway by which Ins(1,4,5)P3 is metabolized (see Ref. 2 for a review) has led to intensive research into the possibility that some of the ensuing products also have important cellular activities. For example, Ins(1,3,4,5)P4, which is formed from Ins(1,4,5)P3 by the action of a 3-kinase (3-5), may modulate cellular Ca2+ fluxes (6).
Among some of the recent developments in inositol phosphate metabolism has been the discovery by two independent laboratories that in liver (7) and adrenal glomerulosa cells (8) the dephosphorylated metabolite of Ins(1,3,4,5)P4, i.e. Ins(1,3,4)P3, is itself rephosphorylated. In order to understand the functions and control of these reactions, it is first necessary to characterize the products. The two groups of workers (7,8) that initially reported Ins(1,3,4)Pj could be phosphorylated noted that the resultant InsP4 could be chromatographically resolved from Ins(1,3,4,5)P4. Further experiments indicated that the InsP4 did not have two adjacent hydroxyl groups (7, 8, 10) since it was resistant to oxidation by periodate (see also Refs. 11-13). The authors of these studies proposed that the Impl was Ins(1,3,4,6)P4 (7, 8, lo) , but they made the untested assumption that there was no isomerization associated with the phosphorylation, so these identifications are not definitive. Subsequently, Stephens et al. (9) found that brain also had the capacity to phosphorylate Ins(1,3,4)P3. These workers made no assumptions concerning isomerization, but because of their use of more elaborate techniques, they were able to prove that Ins(1,3,4,6)P4 was formed from Ins(1,3,4)P3. However, the proliferation of enzymes involved in inositol phosphate metabolism makes it unreliable to extrapolate results from brain and apply them to other tissues.
These uncertainties prompted a definitive analysis of the products of Ins(1,3,4)P3 phosphorylation in liver. The metabolic pathway has been characterized by incubating liver homogenates, and subfractions derived therefrom, in media designed to imitate physiological ionic strength and pH. This led to the novel observation that there were two Inspa products, which were unequivocally determined to be Ins (1, 3, 4, 5)P4 and Ins(1, 3, 4, 6) P4.
When the Ins(1,3,4)P3 phosphorylation pathway was discovered (7, 8) , it was suggested (7) that it might produce precursors for InsPS. Such reactions may be physiologically important since InsPS has been detected in a number of cell types (e.g. Refs. 9, [14] [15] [16] [17] [18] [19] and 31) and may be an extracellular signal (19) . Both adrenal glomerulosa cells (20) Ref. 12 and "Results") .
Saponin and nonradioactive Ins(1,3,4,5)P4 were purchased from Calbiochem. Dithiothreitol, L-tallose, D-iditol, NAD+, protein kinase A, poly01 dehydrogenase (EC 1.1.1.14), sodium phosphocreatine, creatine phosphokinase, and protease inhibitors were purchased from Sigma. L-Altritol was produced by reduction of L-tallose with borohydride (see below). Sodium periodate, periodic acid, and sodium borohydride were purchased from Aldrich. Erythrocyte ghosts were prepared as described in Ref. 21 .
Preparation of Liver Hornogenates and Subfractions-Liver homogenates (30% w/v) were prepared from 200-250-g Sprague-Dawley rats as described previously (7), except that the homogenization medium was 0.25 M sucrose, 10 mM BisTris (pH 7.2 with NaOH), 5 mM sodium azide, 10 pg/ml leupeptin, 4 mg/ml iodoacetamide, 0.1 pg/ml trypsin inhibitor, and 20 pg/ml phenylmethylsulfonylfluoride. 100,000 X g supernatants and pellets, each resuspended to a 30% concentration (weight of original liver/volume), were prepared as in Ref. 7 . At a flow rate of 0.5 ml/min, 10 ml of the supernatant was loaded onto a Mono-& H/R 10/10 ion-exchange FPLC column (i.e. from 0 to 20 min). The column was then eluted with a gradient derived from two buffers. Buffer A contained 0.25 M sucrose, 10 mM BisTris (pH 7.2 with NaOH), and 5 mM sodium azide. Buffer B consisted of buffer A plus 1 M NaCl. The gradient was: 28-90 min, B increased from 0 to 30%; 90-100 min, B increased to 100%,100-110 min, B = 100%; 110-120 min, B decreased to 0%. Fractions of 1 ml were collected, and these were stored at -20 "C until required; protein assays were performed as described in Ref. 32 .
Assay of Inositol Phosphatases and Kinases-Tissue samples were incubated with the appropriate 3H-labeled inositol phosphate in 0.5 ml of medium containing 120 mM KCI, 20 mM Hepes (pH 7.2 with KOH), 10 mM MgSO,, 5 mM ATP, 1 mM EGTA, and 0.2 mg/ml tration of either 0.1 or 1 y~ (7). Other additions are given in the saponin. In some experiments, Ca2+ was added to give a free concenlegends to the figures and tables. Incubations were acid-quenched (21) and, when samples were analyzed with gravity-fed Bio-Rad columns (0.6 ml, AG1-X8, 200-400 mesh, formate form), they were first neutralized as in Ref. 7, applied to the column in 10 ml of water, and then the following 10-ml fractions were eluted for Imp1, 180 mM ammonium formate; InsPn, 0.4 M ammonium formate, 0.1 M formic acid InsPB, 0.8 M ammonium formate, 0.1 M formic acid; InsP4, 1.05 M ammonium formate, 0.1 M formic acid; InsPs, 2 M ammonium formate, 0.1 M formic acid (16, 22) .
Acid-quenched incubations that were analyzed by HPLC (with a 4.6 X 250-mm Adsorbosphere SAX 5-pm column, Alltech Associates, Deerfield, IL) were first neutralized with a minor modification (21, 25) of the Freon/octylamine method (30) with >80% recovery of all inositol phosphates. InsP5 and InsPs were separated as described in Ref. 17 . In other experiments the gradient was modified so that as the column aged and elution times decreased, the separation of the Impl isomers was maintained without altering their relative elution positions; buffer A was water, buffer B was 0.85 M ammonium dihydrogen phosphate, pH 3.35 with H2PO4 (17) . From 0 to 4 min, Buffer B was 0%; 4 to 5 min, B increased to 21%; 5 to 55 min, B = 21%; 55 to 56 min, B increased to 32%; 56 to 120 min, B remained at ~~ * K. Oliver and J . W. Putney, Jr., unpublished data. 32%; 120 to 160 min, B increased to 100%; 160 to 180 min, B remained at 100%. The flow rate was 1 ml/min. Routinely, elution times were determined for 3H-labeled Ins(l,4)P2, Ins(1,3,4)P3, Ins(1,3,4,5)P4, and 1nsP6. During a column's useful life, Ins(1,3,4)P3 eluted between 30 and 50 min, InsP, isomers eluted between 60 and 110 min, and InsP5 eluted between 105 and 170 min.
In order to recover inositol phosphates for structural analysis, the HPLC eluate was divided into 0.5-ml fractions, and 10-pl aliquots of each fraction were added to scintillant to locate the radioactive peaks of interest. In other experiments, the radioactivity in the HPLC eluant was measured with an on-line detector (Radiomatic Flo-one) using a 1:4 v/v mixture of e1uate:Picoflow 4 scintillant (Packard Instrument Co.). The counting efficiency was approximately 20% throughout the gradient.
Structural Analyses of Inositol Phosphates-Desalted samples of inositol phosphates were incubated a t 25 "C for 40 h in the dark with either sodium periodate (for JnsPB) or periodic acid (for InsP4, pH 3.0 with NaOH).3 Reduction and dephosphorylation were as described by Stephens et al. (9, 12) , except that the elution through H+-Dowex was performed at 0-4 "C. The resultant polyols, in 10 gl of water added to 2000 dpm of ['4C]inositol and 2000 dpm of ["C]xylitol, were applied to a Polybore-Pb column (4.6 X 220 mm, Pierce Chemical Co.) and eluted at 80 "C at 0.2 ml/min with water, which was degassed by sparging with helium. Fractions of 1 min were collected. The identity of the [3H]polyols was determined by their RF values relative to ["C] inositol. The RF value of ["C]xylitol was typically 1.5; RF values for standards (100 gg) of altritol (=1.25) and iditol (=1.9) were also determined in separate runs from the absorbance of the eluant at 200 nm.
Alkaline hydrolysis of InsP4 and InsPS was as described by Stephens et al. (9, 12) except that the incubations with ammonia were performed for 120 h. The ammonia was removed by lyophilization, and then the inositol monophosphates were isolated using a Bio-Rad anion-exchange column (see above), desalted (see below), and separated by HPLC (9). Typical elution times were: Ins-l-P/Ins-3-P, 35 min; Ins-2-P, 40 min; Ins-5-P, 50 min; Ins-C-P/Ins-B-P, 53 min. 100 mM Tris (pH 8.3 with HCl), 20 mM NAD+, 60 g M L-altritol, and Polyol dehydrogenase assays were performed a t 30 "C in 1.06 ml of 1.2 Sigma units/ml poly01 dehydrogenase. After a steady base line was attained (20 min), the following additions were made (in 0.09 ml of incubation buffer without dehydrogenase): either 6000 dpm of genuine ~-[~H]altritol or 1000 dprn of [3H]altritol of unknown chirality (see "Results"). After a further 210 min reactions were quenched by their addition to 3 ml of Amberlite MB-3 resin. L-Altritol oxidation between 20 and 210 min was assessed by measuring NAD+ reduction at 340 nm, assuming a 1:1 stoichiometry. The Amberlite was washed with 4 X 1-ml aliquots of water, the eluates were combined and lyophilized, then added to ["Clxylitol and ['4C] inositol and chromatographed on the Polybore HPLC column (see above).
Some samples of [3H]InsP4 were incubated for 1 h at 37 "C with 50 yl of packed erythrocyte ghosts in 0.5 ml of medium containing 20 mM Hepes (pH 7.0 with NaOH), 0.2 mg/ml saponin. Incubations were acid-quenched (7), and the [3H]InsP3 was isolated by HPLC (see above) and then desalted as described below.
Desalting Procedures-InsP fractions in 10 ml of 180 mM ammonium formate were desalted by elution through a 1.5-ml column of Bio-Rad cation-exchange resin (200-400 mesh, H+ form), and the eluate was lyophilized. HPLC fractions containingeither InsP3, InsP,, or InsP5 were neutralized (23) and rechromatographed on gravity-fed Bio-Rad anion exchange columns (see above). Samples were then desalted using a 0.1-ml anion-exchange column (see Ref. 24) , except that the InsPs was obtained by washing the column with 3 X 1-ml aliquots of 0.1 M HC1 and then eluting the InsPa with 3 X 1-ml aliquots of 2 M HCl. The acid was then removed by lyophilization.
RESULTS
Characteristics of Ins(1,3,4)P3 Metabolism-Liver homogenates were incubated with 10 nM [3H]In~(1,3,4)P3 in the presence of 5 mM MgATP, and the reaction products were analyzed by HPLC. Fig. 1 shows data from a 5-min incubation, after which around half of the Ins(1,3,4)P3 was metabolized by both dephosphorylation to ZnsPz and phosphorylation to InsP4. About 1.3% of the original Ins(1,3,4)P3 was phosphorylated to an InsP5. This is the first demonstration that, L. R. Stephens, personal communication. in liver, Ins( 1,3,4)P3 can be phosphorylated to InsP5, although the amount formed was small in comparison with the other routes by which Ins(1,3,4)P3 was metabolized. Fig. 1 also reveals that there were two InsP, peaks. There are no previous reports that two InsP, isomers can be formed from Ins( 1,3,4)P3. In this experiment, the minor of the two InsP,s accounted for 2% of total Ins( 1,3,4)P3 metabolites. This minor peak, which co-eluted precisely with Ins( 1,3,4,5)P4 standards (data not shown) is described hereafter as peak B. The earlier eluting and major InsP4 is designated as peak A.
At least one of the InsPI isomers in Fig. 1 (but it is not clear which) has to be formed by direct phosphorylation of Ins(1,3,4)P3 (Ins(l,4)P2, Ins(3,4)P2, and Ins(1,3)Pz are not phosphorylated by liver (23)). However, one of the two InsP, isomers could be formed by either (a) dephosphorylation of InsP5, ( b ) isomerization of the other InsP4, or ( c ) phosphorylation of Ins(1,3,4)P3. Fig. 1 also does not reveal which of the two InsP4 isomers is the precursor for InsP5. These problems may be resolved by separation of the enzymes that synthesize and catabolize these compounds.
A partial resolution of enzyme activities was achieved by studying the time course of Ins(1,3,4)P3 metabolism in homogenates and also in 100,000 x g supernatant and particulate fractions (Fig. 2) . During the course of 15-min incubations, liver homogenates almost completely metabolized the added Ins(1,3,4)P3, and approximately equal proportions were phosphorylated and dephosphorylated. The rates of Ins(1,3,4)P3 dephosphorylation (appearance of Inspa plus InsP) and phosphorylation (appearance of total InsP4) closely followed exponential kinetics. This time course reflects the use of limiting substrate concentrations (10 nM) which are therefore metabolized with approximately first-order kinetics. In agreement with earlier studies (25) the sum of cytosolic and particulate Ins(1,3,4)P3 phosphatase activities exceeded that in the parent homogenate (Fig. 2) . Fig. 2 shows that the supernatants contained about 75% of the homogenate enzyme activity that produced the major InsP, (peak A, see above). Williamson and co-workers (26) reported that Ins( 1,3,4)P3 kinase was present in liver cytosol, but they did not report what proportion of total cellular activity was particulate nor did they report that two InsP4 products were formed. The rate of InsPs synthesis was greatest in the incubations with supernatants, although InsP5 was only 3% of all metabolites after nearly 90% of the Ins(1,3,4)P3 had been metabolized. InsP, (peak A) accumulated before InsP5, indicating that the latter was not the precursor of the former. In incubations of Ins(1,3,4)P3 with homogenates the minor InsP, (peak B) was less than 2% of Ins(1,3,4)P3 metabolites. This InsP4 was more prevalent in incubations of soluble fractions (5% of all metabolites) but was only just detectable in incubations of particulate fractions (0.5% of metabolites).
Structural Characterization of the Products of Ins(l,3,4)P3 Phosphorylation-In order to identify the InsP4 isomers produced upon phosphorylation of Ins(1,3,4)P3, the kinase activity was concentrated by anion-exchange chromatography (Fig.  3) . Ins(1,3,4)P3 kinase activities were well resolved from Ins(1,3,4,5)P4 5-phosphatase. The two kinase activities coeluted, peaking at fraction 34, and these were resolved from Ins(1,3,4)P3 phosphatase activity, showing that the substrate for phosphorylation was Ins(1,3,4)P3 and not one of its metabolites. Fig. 4 shows that in fraction 34, 16% of total Ins(1,3,4)P3 kinase activity produced the minor InsP, (peak B). Since no InsP5 was formed in these incubations (Fig. 4) , both InsP, isomers must be formed from Ins(1,3,4)P3.
Fraction 34 in Fig. 3 , which contained the peak Ins(1,3,4)P3 kinase activity, was incubated as described in the accompanying legend with 0.5 pCi of [3H]Ins(1,3,4)P3. The resultant InsP, isomers were isolated by HPLC and desalted as described under "Experimental Procedures." The structural analyses were then undertaken, first by determining the sensitivity of the InsP, isomers to periodate. Under appropriate conditions, periodate will oxidize an InsP, only if it has two adjacent hydroxyls. Thus Ins(1,3,4,5)P4 is resistant such that after incubation with periodate, followed by reduction and dephosphorylation, inositol is the resultant poly01 (11-13). On the other hand Ins(3,4,5,6)P4 is sensitive to periodate and should ultimately yield iditol (12). However, "periodate sensitivity'' is a relative term; Ins( 1,2,3,4)P4, which is predictably periodate-sensitive, is not oxidized under some conditions (27) . Thus Ins(1,3,4,5)P4 and Ins(3,4,5,6,)P4 were used as controls that the periodate method was performing as expected.
In the experiments described by Table I , Ins(1,3,4,5)P4 standards were virtually 100% periodate-resistant, and after reduction and dephosphorylation only inositol was formed. Standards of putative Ins(3,4,5,6)P4 were oxidized by periodate, largely yielding iditol, although 24% of the resultant polyols were inositol. Thus either the original samples of Ins(3,4,5,6)P4 were contaminated with another inositol phosphate or some of the putative Ins(3,4,5,6)P4 had resisted attack by periodate. This problem was not investigated further. In any case the data indicate that the experimental conditions would detect at least 76% of a periodate-sensitive InsP,. Both of the InsP4 products of Ins(1,3,4)P3 kinase yielded inositol after incubation with periodate followed by reduction and dephosphorylation (Table I) . However, a number of InsP4 isomers are resistant to periodate (see Table 111 ) SO the data in Table I by themselves do not identify the products of InsP3 kinase.
The phosphate groups around an inositol ring can be eliminated by alkaline hydrolysis (9, 13, 16). If the reaction is stopped when inositol monophosphates are formed, the re- (1,3,4) P3 metabolism in the presence of ATP. Aliquots (60 pl) of either liver homogenates (U), 1000,000 X g supernatants ( -) , or particulate fractions (A-A)
FIG. 2. Time course of Ins
were incubated with 0.1 pCi of Ins(1,3,4)P3, and the products were analyzed by HPLC as described under "Experimental Procedures. was determined by incubating 10-pl aliquots of fractions for 10 min with 10,000 dpm of [3H]Ins(1,3,4)P3; samples were analyzed with gravity-fed columns. Ins(1,3,4)P3 kinase activity was assayed with 0.1 pCi of [3H]Ins(1,3,4)P3, and the reaction products were analyzed by HPLC: W, InsP4 (peak A, i.e. earlier peak in Fig. 1) ; W, InsPl (peak B, i.e. later peak in Fig. 1 ). The reaction products of the remaining incubations were analyzed using gravity-fed columns. Ins(1,3,4,6)Pl kinase activity ( 8 -4) was determined in incubations containing 80-pl aliquots of fractions incubated with 4000 dpm of I3H] Ins(1,3,4,6)P4 for 1 h. The incubation media were supplemented with 10 mM phosphocreatine, 5 units/ml creatine phosphokinase, and 1 mM dithiothreitol. Ins(1,3,4,5)P4 5-phosphatase activity (A-A) was determined with 5-pl aliquots of fractions incubated for 10 min with 10,000 dpm of [3H]Ins(1,3,4,5)P4, but the medium did not contain ATP. Recoveries of all enzymes exceeded 85%. Data are from a single experiment, typical of three. InsP5 were subjected to alkaline hydrolysis, and then the resultant [3H]InsP isomers were extracted and separated as described under "Experimental Procedures." "Peak A" and "peak B" refer, respectively, to the earlier and later eluting peaks in Fig. 1 . "Peak 1" and "peak 2" indicate that these isomers of InsP, were formed from, respectively, the earlier and later eluting of the two peaks of Ins(1,3,4,6)P4 kinase described in Fig. 3 . Data for InsP4 are means and standard errors of three independent determinations. Data for InsP5 were obtained from two independent determinations. (1,3,4,6 )P4 kinase. Ins(1,3,4)P3 kinase activity was assayed as described in the legend to Fig. 3 with 0.1 pCi of [3H]Ins(1,3,4)P3 incubated with 10-pl aliquots of fraction 34 obtained from the anion-exchange chromatography experiment described by Fig. 3 . The products were separated by HPLC using a newer column than in Fig. 1 (hence the inositol phosphates eluted later, see "Experimental Procedures"). In this and two further experiments, the two InsP4 isomers were formed in the ratio of 84 f 2:16 -t 2.
TABLE I

Polyols formed f r o m various samples of [3HlInsP4 incubated with
periodate followed by reduction and dephosphorylation 3,000-10,000 dpm of the designated [3H]InsP4 were incubated with periodic acid, reduced with borohydride, dephosphorylated, and analyzed by HPLC as described under "Experimental Procedures." "Peak A" and "peak B" refer, respectively, to the earlier and later eluting peaks in Fig. 1 . Data are means and standard errors from four independent determinations. sultant mixture of isomers is indicative of the structure of the parent compound. Note that the nonchiral techniques used in this paper do not distinguish between enantiomeric pairs of monophosphates (i.e. Ins-l-P/Ins-3-P and Ins-4-P/Ins-6-P). Alkaline hydrolysis of the peak A InsP4 yielded a mixture of Ins-l-P/Ins-3-P and Ins-4-P/Ins-6-P (Table 11) . Only one InsP, can product this pattern of monophosphates, i.e. Ins(1,3,4,6)P4 (Table 111 ). This compound would be predicted to be insensitive to periodate, which it is (see above). This is the first unequivocal structural characterization of this isomer in liver (see the Introduction). Note that the yield of Ins-3-P/Ins-l-P was rather less than Ins-4-P/Ins-6-P (Table 11) . The reason for this is unclear, but a disproportionate yield of monophosphates is a peculiarity of this technique (Table 11 , data not ~h o w n ) .~ After alkaline hydrolysis, the peak B InsP4 yielded a mixture of Ins-l-P/Ins-3-P, Ins-5-P, and Ins-4-P/Ins-6-P. Two possible periodate-resistant InsP4 isomers could give this pattern of monophosphates: Ins(1,3,4,5)P4 and Ins(1,3,5,6)P4 (Table 111 ). Both are equally plausible products, since they could be produced by either 5-kinase action on Ins (1,3,4 kinase activity The table lists all possible InsPl isomers and shows their expected reaction to periodic acid and also the monophosphates expected to form from them upon alkaline hydrolysis. Additionally are listed the results obtained for the two InsP4 isomers under study ( " A and "B" refer, respectively, to the earlier and later eluting peaks in Fig. 1 ).
Key: + indicates positive; -indicates negative). 
or by isomerization of Ins(1,3,4,6)P4.
The [3H]InsP4 (peak B) now known to be either Ins(1,3,4,5)P4 or Ins(1,3,5,6)P4 (see above) was found to be dephosphorylated by incubation with erythrocyte ghosts (data not shown). Since the ghosts contain Ins(1,3,4,5)P4 5-phosphatase activity, it would be expected that if the unknown InsP4 were Ins(1,3,4,5)P4, then the InsP3 product would be Ins(1,3,4)P3. However, if the original InsP, were Ins(1,3,5,6)P4, it is not inconceivable it might also be a substrate for 5-phosphatase. In such a case, Ins(1,3,6)P3 would be the product. This is the enantiomer of Ins(1,3,4)P3, and enantiomeric pairs of inositol phosphates are indistinguishable by nonchiral analytical techniques. Fortunately, Ins(1,3,6)P3 yields D-altritol upon periodate oxidation, reduction, and dephosphorylation, whereas similar treatment of Ins(1,3,4)P3 gives L-altritol. It was considered that poly01 dehydrogenase might distinguish between enantiomers of altritol, since this enzyme oxidizes L-iditol 10 times more rap-idly than D-iditol (12). Therefore poly01 dehydrogenase was incubated with ~-[~H]altritol and nonradioactive L-altritol. The enzyme oxidized only 25% of the L-altritol. The resultant [3H]polyol eluted just before standards of inositol upon HPLC (Fig. 5 ). Other data demonstrate that poly01 dehydrogenase preferentially attacks the L-enantiomer of altritol, although the specificity is more marked than the 11-fold specificity shown toward L-iditol over D-iditol (12, 35) .
The [3H]InsPs produced by incubation of [3H]InsP4 (peak B) with erythrocyte ghosts was desalted and then incubated with periodate, reduced, and dephosphorylated. The resultant ['H]altritol was identified by its RF value relative to inositol (1.26 in Fig. 5 and see under "Experimental Procedures"). The proportion of [3H]altritol of unknown chirality that was oxidized by poly01 dehydrogenase (26%) was almost identical to that for ~-[~H]altritol (Fig. 5) ; thus the unknown altritol must also have been the L-enantiomer. This identifies the parent InsP3 as Ins(1,3,4)P3, and therefore the original InsP4 (peak B) was Ins(1,3,4,5)P4. Now that the two InsP4 isomers were characterized, 10,000 dpm of each were individually incubated in the "physiological'' buffer (see "Experimental Procedures") plus 10 ~1 of fraction 34 (in Fig. 3 ) for 15 min. There was no isomerization of Ins(1,3,4,5)P4 to Ins(1,3,4,6)P4 or vice versa (data not shown), indicating that both InsP, isomers were direct products of Ins(1,3,4)P3 phosphorylation.
Ins(1,3,4,6)P4 was itself incubated with fractions obtained by anion-exchange chromatography of liver supernatant (Fig.  3 ). This InsP, was phosphorylated to InsP,, and two peaks of kinase activity were observed. The earlier and later eluting peaks are hereafter referred to as peaks 1 and 2, respectively. In Fig. 3 , and two further experiments, peak 1 contained the majority of total activity (70 & 4%). The products of Ins(1,3,4,6)P4 kinase (Fig. 3) were also analyzed. Aliquots (100 pl) of fractions from both peaks were each incubated with 0.04 pCi of Ins( 1,3,4,6)P4 for 1 h as described in the legend to Fig. 3 . The resultant InsP, was isolated, desalted, and hydrolyzed in ammonia (see "Experimental Procedures"). The InsP5 produced by peak 1 was hydrolyzed to the following monophosphates: Ins-l-P/Ins-3-P, Ins-5-P, and Ins-4-P/Ins-6-P (Table 11 ). This characterizes the InsP5 as Ins (1, 3, 4, 5, 6 )P5 and demonstrates for the first time that Ins(1,3,4,6)P4 5-kinase is present in liver.
The products of Ins(1,3,4,6)P4 kinase activity in peak 2, upon alkaline hydrolysis, yielded Ins-l-P/Ins-3-P, Ins-2-P, Ins-5-P, and Ins-4-P/Ins-6-P (Table 11 ), indicating that there was more than one InsP5 isomer, and possibly also an InsP6. The yield of Ins-2-P was relatively low (Table 11) , but because the monophosphates were not produced in equal proportions, it is not possible to quantify the amount of the isomer that gave rise to Ins-2-P. However, the formation of InsPs by the enzymes in peak 2 was excluded since the products (data not shown) eluted as a single InsP, peak during an HPLC procedure that is known to separate InsP5 from InsP6 (see under "Experimental Procedures"). Additionally, when 20,000 dpm of Ins (1, 3, 4, 5, 6 )P5 was incubated in the "physiological" medium with 100 p1 of a 1:l mixture of fractions 21 and 22 (which contained most peak 2 kinase activity), no further phosphorylation was observed (data not shown). The parsimonious interpretation of the data in Table I1 is that peak 2 contains both Ins(1,3,4,6)P4 5-kinase and Ins(1,3,4,6)P4 2-kinase. The latter enzyme has not previously been described, but it accounted for less than 30% of all Ins(1,3,4,6)P4 kinase (Fig. 3) . However, these analyses were performed under firstorder conditions, so in vivo the putative Ins(1,3,4,6)P4 2-kinase may be more than the minor hepatic enzyme activity indicated by these data.
Effect of Ins(l,3,4,5)P4 upon Ins(1,3,4)P3 Kinase Actiuities- Fig. 6 shows that Ins(1,3,4,5)P4 is a potent inhibitor of Ins(1,3,4)P3 kinase. At concentrations between 3 and 10 phi, Ins(1,3,4,5)P4 reduced total Ins(1,3,4)P3 kinase activities by between 40 and 60%. The products of the kinase activity were analyzed by HPLC, which revealed that both 5-and 6-kinase were inhibited to the same extent (data not shown).
CONCLUSIONS
In these studies, as in earlier work (7), liver homogenates and subfractions derived therefrom have been incubated in "physiological" media, and metabolism of inositol phosphates has been measured under first-order conditions. In should be noted that the fluxes of the various metabolites in uiuo are likely to differ from those reported here, in particular because the concentrations of the intermediates are rather higher. At present it is difficult to assess the physiological metabolic fluxes, because there is little information on either the intracellular concentrations of inositol phosphates or kinetic parameters of the various enzymes. Nevertheless, the approach taken here is a valid means of identifying the pathways of inositol phosphate metabolism, and several important new observations have been made. in Fig. 3) were incubated for 10 min with around 10,000 dpm of [3H]
Ins(1,3,4)P3 and various concentrations of Ins(1,3,4,5)P4. Kinase activity was assessed as described under "Experimental Procedures", using gravity-fed columns. Data are means and standard errors from three independent experiments.
When Ins(1,3,4)P3 phosphorylation was first observed (7, 8), it was only tentatively proposed that the resultant InsP4 was Ins(1,3,4,6)P4, because it could not be excluded that isomerization of the InsP, has occurred. Only in brain has Ins(1,3,4)P3 phosphorylation to Ins(1,3,4,6)P4 been definitively characterized (9). The methods used in the latter study have been utilized here, including HPLC, FPLC, periodate oxidation, alkaline hydrolysis, and stereospecific poly01 oxidation. Thus for the first time it has been unequivocally demonstrated that, in liver, Ins(1,3,4)P3 is phosphorylated to Ins(1,3,4,6)P4. A further new observation in this work is the characterization of a second route of Ins(1,3,4)P3 phosphorylation performed by a Ins(1,3,4)P3 5-kinase. The latter novel activity was not observed in earlier experiments with brain (9) or adrenal glomerulosa cells (8, 20) , and it is not yet known if this enzyme is unique to liver.
Under conditions of limited substrate concentrations, 16% of total Ins(1,3,4)P3 phosphorylation was attributable to a 5-kinase. This only became clear once the Ins(1,3,4)P3 5-kinase in liver supernatant was separated from Ins(1,3,4,5)P4 5-phosphatase activity by anion-exchange chromatography. In supernatants, and more profoundly in particulate fractions and in homogenates, the Ins(1,3,4,5)P4 that was formed from Ins(1,3,4)P3 was kept at low levels by the Ins(1,3,4,5)P4 5-phosphatase (7). In stimulated hepatocytes where substrate concentrations are much higher than were used in these experiments, significant levels of Ins(1,3,4,5)P4 were detected (4,26), so the 5-phosphatase activity must be exceeded by the combined activities of the Ins(1,3,4)P3 5-kinase and Ins(1,4,5)P3 3-kinase (3-5). Shortly after the termination of the cell's stimulation, as Ins(1,4,5)P3 levels decay, the Ins(1,3,4)P3 5-kinase could contribute to prolonging intracellular levels of Ins(1,3,4,5)P4 and any associated signaling activity (see Ref. 6 ). For example, Ins(1,3,4,5)P4 may have a role in replenishing the mobilizable Ca2+ pool (6), which can only take place once Ins(1,4,5)P3 has returned to near basal levels. The presence of Ins(1,3,4,5)P4 5-phosphatase and Ins(1,3,4)P3 5-kinase activities represents a "futile cycle" which in other circumstances has been shown to be a highly efficient control point in a metabolic pathway. However, there is no evidence yet that the 5-phosphatase activity is regulated by the hepatocyte (7, 25). Moreover, the activity of Ins(1,3,4)P3 5-kinase (and Ins(1,3,4)P3 6-kinase) in liver supernatants was not altered when the Ca2+ concentration of the medium was increased from 0 to 0.1 pM or to 1 pM (data not shown and Ref. 26 ) nor when 100 ~L M CAMP was added (data not shown).
Further work will be necessary to unequivocally determine if Ins(1,3,4)P3 5-and 6-kinase activities are performed by a single enzyme, but several lines of evidence suggest that this is the case; both activities predominated in the soluble portion of the cell (Fig. 2) , and they co-eluted during anion-exchange FPLC (Fig. 3) . The most striking evidence is that both kinase activities were inhibited to the same extent by Ins(1,3,4,5)P4. There are no direct measurements of Ins(1,3,4,5)P4 levels in receptor-activated hepatocytes, but an indirect estimate of 0.7 p~ (34) has been made, which is rather smaller than Ins(1,4,5)P3 levels (2.5 p~ (28) ). At a concentration of 0.7 p M , Fig. 6 indicates that Ins(1,3,4,5)P4 would inhibit Ins(1,3,4)P3 kinase activity by 13%, which is a physiologically minor effect. However, in brain, the Ins(1,3,4,5)P4 concentration appears to be up to 3-fold greater than that of Ins(1,4,5)P3 (29) . Inhibition of Ins(1,3,4)P3 kinase by Ins(1,3,4,5)P4 may be more important in this tissue and may partly explain why there was no detectable Ins(1,3,4,6)P4 in receptor-activated brain slices (29) , even though this tissue has an active Ins(1,3,4)P3 6-kinase (9).
This work has also shown for the first time that, in liver, Ins(1,3,4,6)P4 can be phosphorylated to Ins(1,3,4,5,6)P5. Brain contains a similar kinase activity (9). Adrenal glomerulosa cells also phosphorylate Ins(1,3,4,6)P4, but the structures of the ensuing products have not been identified (20) . No further phosphorylation of Ins(1,3,4,5,6)P~ to InsPs was detected in liver, but this tissue may contain more than 15 p~ InsPs (31) . The possibility that liver may also synthesize Ins( 1,2,3,4,6)P5 (see above) needs further study, as does the possibility that this isomer may be a precursor for InsPs.
The work reported here has added new complexities and additional enzyme activities to a metabolic pathway that has already proved surprisingly convoluted; Ins(1,3,4)P3 has now emerged as a particularly versatile intermediate, being a precursor for two InsP4s as well as two InsP2s (Fig. 7) . This work has also revealed a relationship between the inositol phosphates produced by receptor activation and the synthesis of a compound, InsPs, that may be an extracellular signal (19) . Liver has a second route of Ins(1,3,4,5,6)P5 production, i.e. by phosphorylation of Ins(3,4,5,6)P4 (16), although the origin of the latter is presently unknown. The interrelationship be-
